ClassID:

110172

C12N2720/12351 - CPC Classification

Classification description:

dsRNA viruses; Details; Reoviridae; Rotavirus, e.g. rotavirus A Methods of production or purification of viral material

Sub-classes:
Recent Application in this class:
#1
20250276053
2025-09-04

ROTAVIRUS VACCINES

#2
20250171502
2025-05-29

RECOMBINANT ROTA VIRUS EXPRESSION SYSTEM AND RECOMBINANT ROTA VIRUSES

#3
20240358825
2024-10-31

Novel Adjuvant Compositions

#4
20210338810
2021-11-04

Adjuvant compositions

#5
20210269488
2021-09-02

Recombinant rotavirus expression system and recombinant rotaviruses

#6
20210024900
2021-01-28

METHODS AND COMPOSITIONS RELATED TO INCREASED ROTAVIRUS PRODUCTION

#7
20200308233
2020-10-01

Truncated rotavirus VP4 protein and application thereof

#8
20200216820
2020-07-09

Method for virus propagation

#9
20190008953
2019-01-10

Adjuvant compositions

#10
20180141978
2018-05-24

Truncated rotavirus VP4 protein and application thereof

#11
20180016561
2018-01-18

Rotavirus-like particle production in plants

#12
20170304434
2017-10-26

Adjuvant compositions

#13
20170173145
2017-06-22

Thermostable spray dried rotavirus vaccine formulation and process thereof

#14
20160188790
2016-06-30

Rotavirus particles with chimeric surface proteins

#15
20160158342
2016-06-09

Vaccines for diseases caused by viruses of the family of reoviridae

#16
20140056940
2014-02-27

Adjuvant compositions

#17
20120107356
2012-05-03

Composition useful as rotavirus vaccine and a method therefor

#18
20110177119
2011-07-21

Stable, dried rotavirus vaccine, compositions and process for preparation thereof

#19
20090324645
2009-12-31

Production of vaccines

#20
20090324641
2009-12-31

Adjuvant compositions

#21
20090130145
2009-05-21

Homogeneous attenuated human rotavirus population

#22
20080063662
2008-03-13

VACCINE

#23
20080057082
2008-03-06

Immunogenic composition of a homogeneous live attenuated human rotavirus population

#24
20060063261
2006-03-23

Production of vaccines

#25
20060051747
2006-03-09

Production of vaccines

#26
20050118140
2005-06-02

Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture